Alice is a Health Economist with Deloitte Access Economics that primarily works in the pharmaceutical and health technology sector in a client facing role with industry and government clients. Alice is an Associate Director in the Health Economics and Social Policy team having joined Deloitte in May 2016. Alice has previously worked in both government and academia and is currently undertaking a Doctor of Philosophy (PhD) part-time at the Australian National University.
Prior to joining Deloitte, Alice worked in policy and advocacy as Regulatory Manager for Medicines Australia, which represents the research-based pharmaceutical industry in Australia. Alice has also previously worked for the Commonwealth Department of Health, working primarily in the Pharmaceutical Benefits Division, and as a Research Assistant at the Australian National University.
Alice is currently undertaking a Doctor of Philosophy (PhD) in pharmacoepidemiology part-time at the Australian National University. Alice’s research is investigating the real world use, safety and pharmacoeconomics of anticoagulants in Australia using large linked health data.
Alice completed a Master of Medical Science from the University of New South Wales and a Bachelor of Behavioural Neuroscience from Monash University. Alice has experience in pharmaceuticals, health economics, policy analysis, as well as quantitative and qualitative research and analysis.